MedPath

aparoscopic peritoneal lavage or resection for generalised peritonitis for perforated diverticulitis: a nationwide multicenter randomised trial

Completed
Conditions
perforated diverticulitis
10013535
10017998
Registration Number
NL-OMON33349
Lead Sponsor
Academisch Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
345
Inclusion Criteria

Patient between 18 and 85 years of age
Free abdominal air on plain abdominal X-ray or CT-scan
Informed consent

Exclusion Criteria

Dementia
Prior sigmoidectomy
Pelvic irradiation
Steroid treatment >20mg daily
Requirement of inotropics due to circulatory insufficiency

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The following main outcomes will be assessed in this trial to compare the<br /><br>various strategies: Poor clinical outcome defined as a combined endpoint<br /><br>consisting of mortality, and major morbidity. Major morbidity includes any of<br /><br>the following events or conditions: reintervention, wound dehiscence/incisional<br /><br>hernia, abscess needing percutaneous drainage, urosepsis, myocardial<br /><br>infarction, renal failure and respiratory insufficiency. This will be the<br /><br>primary outcome in the lavage vs. resectional intervention comparison (LOLA).<br /><br>Stoma-free survival one year after initial surgery, is the only relevant and<br /><br>primary outcome for the comparison of the resectional strategies (DIVA). </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Secondary endpoints are operating time, hospital stay, number of days alive and<br /><br>outside the hospital, incisional hernia, reinterventions within twelve months,<br /><br>health related quality of life, health care utilization and associated costs.</p><br>
© Copyright 2025. All Rights Reserved by MedPath